• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用数学模型进行经济评估:米索前列醇预防的案例

Economic evaluation using mathematical models: the case of misoprostol prophylaxis.

作者信息

Gabriel S E

机构信息

Department of Health Sciences Research, Mayo Clinic, Rochester, MN 55905, USA.

出版信息

J Rheumatol. 1995 Jul;22(7):1412-4.

PMID:7562787
Abstract

Using misoprostol prophylaxis as an example, many of the methods employed in economic analyses that incorporate mathematical models were described. These included: decision analysis, cost effectiveness analysis (including incremental cost effectiveness analysis), one-way, multi-way, and probabilistic sensitivity analysis, and the estimation of quality adjusted life years for use in cost utility analysis. In the case of misoprostol prophylaxis, the cost effectiveness analysis demonstrated that, compared to the no prophylaxis alternative, prophylaxis cost an extra $650, on average, for every additional ulcer prevented, and was potentially cost saving for some high risk groups. The cost utility analysis demonstrated that prophylaxis resulted (on average) in modest additional costs and no additional quality of life benefits. Sensitivity analysis demonstrated that, at worst, prophylaxis reduced quality of life; at best, the incremental cost effectiveness ratio was $9333 for each quality adjusted life-year gained by prophylaxis compared to no prophylaxis. The results of the cost utility analysis also showed that prophylaxis may be cost saving in high risk groups, confirming the results of the cost effectiveness analysis. Finally, and perhaps most importantly, this analysis illustrated the importance of incorporating measures of health related quality of life into economic evaluation.

摘要

以米索前列醇预防为例,描述了经济分析中采用数学模型的许多方法。这些方法包括:决策分析、成本效益分析(包括增量成本效益分析)、单向、多向和概率敏感性分析,以及用于成本效用分析的质量调整生命年的估计。在米索前列醇预防的案例中,成本效益分析表明,与不进行预防的方案相比,预防措施平均每多预防一例溃疡要额外花费650美元,并且对一些高危人群可能具有成本节约效果。成本效用分析表明,预防措施(平均)导致适度的额外成本,且未带来额外的生活质量改善。敏感性分析表明,最坏的情况是预防措施降低了生活质量;最好的情况是,与不进行预防相比,预防措施每获得一个质量调整生命年的增量成本效益比为9333美元。成本效用分析的结果还表明,预防措施在高危人群中可能具有成本节约效果,这证实了成本效益分析的结果。最后,也许最重要的是,该分析说明了将健康相关生活质量指标纳入经济评估的重要性。

相似文献

1
Economic evaluation using mathematical models: the case of misoprostol prophylaxis.使用数学模型进行经济评估:米索前列醇预防的案例
J Rheumatol. 1995 Jul;22(7):1412-4.
2
Prolonged enoxaparin therapy to prevent venous thromboembolism after primary hip or knee replacement. A cost-utility analysis.延长依诺肝素治疗以预防初次髋关节或膝关节置换术后静脉血栓栓塞。一项成本效益分析。
Arch Orthop Trauma Surg. 2004 Oct;124(8):507-17. doi: 10.1007/s00402-004-0720-3. Epub 2004 Sep 10.
3
Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV.职业性接触艾滋病毒后化学预防的成本效益
Arch Intern Med. 1997 Sep 22;157(17):1972-80.
4
Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.质量调整生命年在儿科护理中缺乏质量:对已发表的儿童健康成本效用研究的批判性综述。
Pediatrics. 2005 May;115(5):e600-14. doi: 10.1542/peds.2004-2127.
5
Preferences for health outcomes and cost-utility analysis.对健康结果的偏好与成本效用分析。
Am J Manag Care. 1997 May;3 Suppl:S8-20.
6
Cost-effectiveness analysis of alternative first-trimester pregnancy termination strategies in Mexico City.墨西哥城孕早期不同妊娠终止策略的成本效益分析。
BJOG. 2009 May;116(6):768-79. doi: 10.1111/j.1471-0528.2009.02142.x.
7
Cost-utility analysis of cataract surgery in the second eye.第二只眼白内障手术的成本效用分析
Ophthalmology. 2003 Dec;110(12):2310-7. doi: 10.1016/S0161-6420(03)00796-6.
8
Cost-effectiveness analysis of palivizumab in premature infants without chronic lung disease.帕利珠单抗用于无慢性肺病早产儿的成本效益分析。
Arch Pediatr Adolesc Med. 2006 Oct;160(10):1070-6. doi: 10.1001/archpedi.160.10.1070.
9
Cost effectiveness of replacing diclofenac with a fixed combination of misoprostol and diclofenac in patients with rheumatoid arthritis.类风湿关节炎患者中用米索前列醇与双氯芬酸固定组合替代双氯芬酸的成本效益
Arthritis Rheum. 1999 Nov;42(11):2293-302. doi: 10.1002/1529-0131(199911)42:11<2293::AID-ANR6>3.0.CO;2-1.
10
Cost-effectiveness analysis in severe mental illness: outcome measures selection.重度精神疾病的成本效益分析:结局指标的选择
J Ment Health Policy Econ. 2007 Jun;10(2):101-8.

引用本文的文献

1
Systematic review of the cost effectiveness of prophylactic treatments in the prevention of gastropathy in patients with rheumatoid arthritis or osteoarthritis taking non-steroidal anti-inflammatory drugs.对类风湿关节炎或骨关节炎患者服用非甾体抗炎药时预防性治疗预防胃病成本效益的系统评价。
Ann Rheum Dis. 2000 Oct;59(10):753-9. doi: 10.1136/ard.59.10.753.
2
The cost effectiveness of misoprostol prophylaxis alongside long-term nonsteroidal anti-inflammatory drugs. Implications of the MUCOSA trial.
Pharmacoeconomics. 2000 Mar;17(3):295-304. doi: 10.2165/00019053-200017030-00007.
3
Economic evaluation of the management of pain in osteoarthritis.骨关节炎疼痛管理的经济学评估
Drugs. 1996;52 Suppl 3:48-58. doi: 10.2165/00003495-199600523-00008.